Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.

by Tanja Lucas, Karim Benihoud, Frédéric Vigant, Christoph Q Schmidt, Andreas Wortmann, Max G Bachem, Thomas Simmet, Stefan Kochanek
Published 2015-01-01

The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors

by Sara A Byron, Huaibin Chen, Andreas Wortmann, David Loch, Michael G Gartside, Farhad Dehkhoda, Steven P Blais, Thomas A Neubert, Moosa Mohammadi, Pamela M Pollock
Published 2013-08-01